Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post‐Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho

Background Elevation of FGF23 (fibroblast growth factor 23) and decreased Klotho levels have been associated with various cardiovascular and renal diseases. However, the combined study of the FGF23–Klotho axis in ischemic heart disease remains elusive. Methods We analyzed the associations between ci...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sara Vázquez‐Sánchez, Ana Blasco, Marina Polo‐Salguero, Laura Mourino‐Álvarez, Marta Gil‐Fernández, Nerea Corbacho‐Alonso, José Alberto Navarro‐García, Elisa Mercado‐García, Laura González‐Lafuente, Elena Rodríguez‐Sánchez, Daniel González‐Moreno, Alberto Pérez‐Gómez, Andrea Matutano, Jesús Vázquez, Juan Antonio López, María Fernández‐Velasco, María G. Barderas, Gema Ruiz‐Hurtado
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-02-01
coleção:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	FGF23 ischemic heart disease Klotho mortality myocardial infarction
Acesso em linha:	https://www.ahajournals.org/doi/10.1161/JAHA.125.045175
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!